Applications in MS: Meeting Modern Deformulation Challenges, June 19, 2018 | ACD/Labs
ACD Labs Logo


Applications in MS: Meeting Modern Deformulation Challenges

June 19, 2018, 10:00 EST | 15:00 GMT | 16:00 CET

Current deformulation scientists face MASSive exSPECtations—they are required to detect, screen, and identify unknowns with increasing efficiency despite shrinking analytical group sizes, pressure to perform more diverse activities, increased outsourcing of work, and slow, tedious, and error-prone methods. As a result analysts are left with much less time to devote to complex deformulation projects, while being expected to streamline existing analytical procedures.

Watch this webinar to see how ACD/Labs' MS tools can ensure you meet your own MASSive exSPECtations in deformulation! We'll discuss our industry leading unknown identification MS tools, which will enable you to meet your deconvolution challenges through an effective and efficient workflow that isolates all unknowns, rapidly screens them against chemical databases, and transparently identifies the best structure candidate(s).

Watch on Demand

Enter your contact info to watch the webinar today!

Intended Audience

  • Mass Spectrometrists
  • Synthetic/Medicinal/Analytical Chemists
  • Scientists involved in structure deformulation and verification
  • Natural Product Chemists

Learning Objectives

In this webinar you will learn how to use ACD/Labs MS analysis software to:

  • Automatically separate all chromatographic components
  • Rapidly screen accurate mass data against various databases
  • Efficiently curate lists of structures to only relevant candidates
  • Easily identify the best structure
  • Effortlessly report and collaborate on results

Presented By

Anne Marie Smith

Dr. Anne Marie Smith (Application Scientist) received her Ph.D. in Chemical Biology from McMaster University where she developed MALDI-MS based assays for screening aminoglycoside kinases. After graduating she was employed as an Associate Scientist with Gilead Sciences in Edmonton, Alberta where the majority of her work focused on impurity identification by LC-MS and LC method development. She later held a position at Piramal Healthcare in Aurora, Ontario as an Analyst where she developed methods by LC, GC, and LC-MS. Anne Marie then joined ACD/Labs where she has successfully applied her detailed knowledge of many analytical techniques, especially Mass Spectrometry and Chromatography, as well as hands-on experience with instruments, troubleshooting technical issues, using scientific software packages, and chromatographic method validation.

Richard Lee

Dr. Richard Lee (Senior Manager, Core Capability & Technology) obtained his Ph.D. from McMaster University in Canada, where his area of study focused on strategies for metabolite identification and metabolomics studies. From McMaster, he moved on as a Scientist at the Centre of Probe Development and Commercialization "CPDC" in Hamilton, Ontario, which developed radiopharmaceuticals as imaging agents and therapeutics for oncology. In this capacity, he was involved in a number of initiatives, acting as project leader and technical leader for radiopharmaceuticals candidates, which were ultimately approved for clinical use by Health Canada and the FDA. He has been with ACD/Labs for the past 5 years and has regularly contributed to the development of ACD/Labs' MS tools, with a particular focus on novel metabolite identification solutions.